Companies → Cabot Corporation
Save to list
Remove

Cabot Corporation

United States, Massachusetts, Boston
Description
Cabot is a global specialty chemicals and performance materials company. The company is a leading maker of carbon black, a compound that strengthens tires, hoses, belts, and molded products. It also makes specialty carbons and metal oxides used in automotive, construction, infrastructure, and energy applications. One of the few carbon black manufacturers with a worldwide presence, Cabot's biggest market is China. The company goes back to 1882 when Godfrey and Samuel Cabot opened a carbon black plant in Pennsylvania.
Address:

2 Seaport Ln Ste 1300 Boston

MA

02210-2019 United States

Revenue
Recent news:

Do Options Traders Know Something About Cabot Stock We Don't?

Investors need to pay close attention to CBT stock based on the movements in the options market lately.

Source: Zacks Mar 18, 2026

Is Cabot (CBT) Offering An Opportunity After Recent Share Price Weakness?

If you are wondering whether Cabot's current share price reflects its true worth, this article will walk you through how that value stacks up against a few simple checks. The stock last closed at US$67.76, with returns of 9.5% decline over 7 days, 9.2% decline over 30 days, 1.1% year to date, 14.4% decline over 1 year, 0.6% decline over 3 years, and 39.4% over 5 years. Recent market moves around Cabot have come against a backdrop of ongoing investor interest in materials names and how they...

Source: Simply Wall St. Mar 12, 2026

Storm Fallout and Segment Reset: What's Next for Innospec Stock?

IOSP faces a storm-hit start to 2026 with weaker H1 earnings with recovery now hinges on a second-half rebound in Performance Chemicals and Oilfield Services.

Source: Zacks Mar 9, 2026

What's Driving Innospec Stock in FY26 After the Winter Storm

IOSP faces a storm-hit start to 2026 as lost Performance Chemicals volumes delay recovery, leaving Fuel Specialties to steady results until a second-half rebound.

Source: Zacks Mar 9, 2026

DRAs and Middle East Mix Shift Shape IOSP's FY26 Strategy

Innospec heads into 2026 with storm-hit first half, betting on DRA ramp, Middle East oilfield growth and second-half margin recovery.

Source: Zacks Mar 9, 2026

Coterra Energy (CTRA) Q4 Earnings Lag Estimates

Cabot (CTRA) delivered earnings and revenue surprises of -14.15% and +4.36%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Source: Zacks Feb 26, 2026

NYSE - Delayed Quote - USD
CBT
67.82 -0.77 (-1.12%)
At close March 20 20:00 UTC
Candle
Line
1D
5D
1M
6M
1Y
5Y
Financial Statistics
Valuation Measures
Current
Quarterly
As of 03/22/2026
Market Cap: 3.54 B
Enterprise Value: 4.44 B
Trailing P/E: 11.86
Forward P/E: 10.62
PEG Ratio (5yr expected): N/A
Price/Sales (ttm): 1.01
Price/Book (mrq): 2.25
Enterprise Value/Revenue: 1.23
Enterprise Value/EBITDA: 5.74
Financial Highlights
Profitability and Income Statement
Profit Margin: 8.62%
Return on Assets (ttm): 10.22%
Return on Equity (ttm): 21.83%
Revenue (ttm): 3.61 B
Net Income Avi to Common (ttm): 306.00 M
Diluted EPS (ttm): 5.72
Balance Sheet and Cash Flow
Total Cash (mrq): 230.00 M
Total Debt/Equity (mrq): 65.12%
Levered Free Cash Flow (ttm): 291.62 M
Disclaimer:

IndexBox is not affiliated with, associated with, or endorsed by this company in any way. The information provided on this page, including company details, is solely for informational purposes. IndexBox makes no representations or warranties about the accuracy or completeness of the information provided.

All data and information is provided “as is” for informational purposes only, and is not intended for trading purposes or financial, investment, tax, legal, accounting or other advice. Please consult your broker or financial representative to verify pricing before executing any trade. IndexBox is not an investment adviser, financial adviser or a securities broker. None of the data and information constitutes investment advice nor an offering, recommendation or solicitation by IndexBox to buy, sell or hold any security or financial product, and IndexBox makes no representation (and has no opinion) regarding the advisability or suitability of any investment.